DE60229666D1 - Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i - Google Patents

Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i

Info

Publication number: DE60229666D1
Authority: DE; Germany
Prior art keywords: vaccination; dose; mycoplasma hyopneumoniae; hyopneumoniae; mycoplasma
Prior art date: 2001-07-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60229666T

Other languages

English (en)

Inventor

Robin Lee Keich

Lisa Grace Sabbadini

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Products Inc

Original Assignee

Pfizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2002-06-07

Publication date

2008-12-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60229666(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-06-07 Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc

2008-12-11 Application granted granted Critical

2008-12-11 Publication of DE60229666D1 publication Critical patent/DE60229666D1/de

2022-06-08 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE60229666T 2001-07-02 2002-06-07 Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i Expired - Lifetime DE60229666D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30263601P	2001-07-02	2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en)	2001-07-02	2002-06-07	One dose vaccination with mycoplasma hyopneumoniae

Publications (1)

Publication Number	Publication Date
DE60229666D1 true DE60229666D1 (de)	2008-12-11

Family

ID=23168589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60229666T Expired - Lifetime DE60229666D1 (de)	2001-07-02	2002-06-07	Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i

Country Status (42)

Country	Link
US (3)	US6846477B2 (de)
EP (3)	EP2842569B1 (de)
JP (1)	JP2005515162A (de)
KR (1)	KR20040030785A (de)
CN (3)	CN102872456B (de)
AP (1)	AP2003002937A0 (de)
AR (1)	AR034678A1 (de)
AT (1)	ATE412426T2 (de)
AU (1)	AU2002309109B2 (de)
BG (1)	BG66481B1 (de)
BR (1)	BR0210804A (de)
CA (1)	CA2451626C (de)
CY (1)	CY1108749T1 (de)
CZ (1)	CZ305781B6 (de)
DE (1)	DE60229666D1 (de)
DK (3)	DK2027873T3 (de)
DO (1)	DOP2002000431A (de)
EA (1)	EA009901B1 (de)
ES (3)	ES2729579T3 (de)
GT (1)	GT200200138A (de)
HK (1)	HK1207584A1 (de)
HR (1)	HRP20031079A2 (de)
HU (1)	HU230246B1 (de)
IL (1)	IL159349A0 (de)
IS (1)	IS7076A (de)
MA (1)	MA27047A1 (de)
MX (1)	MXPA03011599A (de)
NO (1)	NO342654B1 (de)
NZ (1)	NZ530106A (de)
OA (1)	OA12638A (de)
PA (1)	PA8549701A1 (de)
PE (1)	PE20030285A1 (de)
PL (1)	PL209773B1 (de)
PT (3)	PT2027873E (de)
SK (1)	SK288010B6 (de)
TN (1)	TNSN03155A1 (de)
TW (1)	TWI329514B (de)
UA (1)	UA78707C2 (de)
UY (1)	UY27366A1 (de)
WO (1)	WO2003003941A2 (de)
YU (1)	YU102203A (de)
ZA (1)	ZA200309698B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY129765A (en) *	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) *	2004-11-24	2006-06-01	Pharmacia & Upjohn Company Llc	Multiple-strain mycoplasma hyopneumoniae vaccines
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
BRPI0620859A2 (pt)	2005-12-29	2011-11-22	Boehringer Ingelheim Vetmedica, Inc.	vacina de combinação multivalente contra pcv2
MX356667B (es)	2005-12-29	2018-06-08	Boehringer Ingelheim Vetmedica Inc	Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
WO2007103042A2 (en) *	2006-03-03	2007-09-13	Merial Limited	Mycoplasma hyopneumoniae vaccine
US20100136060A1 (en) *	2006-11-22	2010-06-03	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (de) *	2006-12-11	2010-10-06	Boehringer Ingelheim Vetmed	Wirksames verfahren zur behandlung von infektionen mit porcinem circovirus und lawsonia intracellularis
DK2094872T4 (da)	2006-12-15	2020-05-18	Boehringer Ingelheim Animal Health Usa Inc	Behandling af anti-PCV2-antistofseropositive svin med PCV2-antigen
EP1941903A1 (de)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxe und Behandlung von PRDC
EP1958644A1 (de)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
UA98812C2 (ru)	2007-11-06	2012-06-25	Вайет Ллк	Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
AU2008347235A1 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 virus like particle with foreign amino acid insertion
CN101236206B (zh) *	2008-01-17	2014-10-15	中国兽医药品监察所	一种猪肺炎支原体重组抗原elisa检测试剂盒
WO2009126356A2 (en) *	2008-01-23	2009-10-15	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) *	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
EP3725328A3 (de) *	2008-06-27	2020-12-23	Zoetis Services LLC	Neue adjuvante zusammensetzungen
CN102448488B (zh)	2009-06-04	2014-10-15	独立行政法人产业技术综合研究所	支原体感染症用疫苗
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CA2793959C (en)	2010-03-25	2019-06-04	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
WO2011141443A1 (en)	2010-05-11	2011-11-17	Intervet International B.V.	Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
CN105797145A (zh) *	2010-07-26	2016-07-27	Qu生物制药公司	免疫原性抗炎组合物
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
CN103154737B (zh) *	2010-08-27	2015-07-15	英特维特国际股份有限公司	疫苗制剂的效价测试
SI2691530T1 (en)	2011-06-10	2018-08-31	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
BR112014022067B1 (pt)	2012-03-07	2022-05-31	Ceva Sante Animale	Composição compreendendo antígeno e lipopolissacarídeo
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
DK2938747T3 (da)	2012-12-28	2019-08-05	Boehringer Ingelheim Vetmedica Gmbh	Fremgangsmåde til fremstilling af en mycoplasma vaccine
CN104981252B (zh)	2012-12-28	2019-06-18	勃林格殷格翰动物保健有限公司	包含支原体抗原的免疫原性组合物
RU2636459C2 (ru) *	2013-02-05	2017-11-23	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
CN104338125A (zh) *	2013-07-29	2015-02-11	普莱柯生物工程股份有限公司	一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
CA2924526A1 (en)	2013-09-19	2015-03-26	Paul Joseph Dominowski	Water-in-oil emulsions comprising immunostimulatory oligonucleotides
MX373884B (es)	2013-10-02	2020-03-26	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
CN110302368B (zh)	2013-11-21	2022-11-04	财团法人农业科技研究院	防治猪霉浆菌感染的组合物
CN105012948B (zh) *	2014-04-18	2019-07-30	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
CN104248753B (zh) *	2014-05-15	2017-07-28	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
BR102014014727B1 (pt) *	2014-06-16	2018-04-03	Ouro Fino Saúde Animal Ltda	COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en)	2014-09-30	2017-11-14	Qatar University	Vaccines against pathogenic Escherichia coli and methods of using the same
KR102508719B1 (ko)	2015-01-16	2023-03-09	조에티스 서비시즈 엘엘씨	구제역 백신
KR20160099223A (ko) *	2015-02-12	2016-08-22	강원대학교산학협력단	마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
WO2018030878A1 (ko) *	2016-08-12	2018-02-15	주식회사 이노백	재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물
RU2668799C1 (ru) *	2017-09-08	2018-10-02	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) *	2017-11-13	2018-06-01	南京大爻网络科技有限公司	一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) *	2018-09-11	2019-07-25	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) *	2019-07-08	2021-11-12	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) *	2023-12-01	2023-12-29	北京瑞阳瑞泰生物科技有限公司	一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0283840A3 (de) *	1987-03-26	1989-08-09	Ml Technology Ventures, L.P.	Mycoplasma hyopneuminiae-Antigen und seine Vewendungen
US5252328A (en) *	1987-03-26	1993-10-12	Martin Marietta Energy Systems, Inc.	Mycoplasma hyopneumoniae antigen and uses therefor
DE3881993T2 (de)	1987-09-18	1993-09-30	Akzo Nv	Mycoplasma-Impfstoff.
HUT65827A (en)	1990-04-02	1994-07-28	Synergen Inc	Polypeptides useful in animal treatment against mycoplasma infections
US6113916A (en) *	1990-05-29	2000-09-05	American Cyanamid Company	Method of enhancing cell mediated immune responses
DK0597852T4 (da)	1990-05-29	2005-10-17	Wyeth Corp	Svinepneumonivaccine og fremgangsmåde til fremstilling deraf
US5565205A (en) *	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (de)	1990-08-27	1992-03-18	Nippon Flour Mills Co., Ltd.	DNA's, die für ein Oberflächenantigen von Mychoplasma hyopneumoniae kodidieren, DNA Fragmente für Primer, rekombinante antigene Peptide und diagnostische Methode für Mycoplasma Pneumoniae vom Schwein unter Nutzung derselben
US5338543A (en) *	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
JPH08502253A (ja)	1992-09-28	1996-03-12	ファイザー・インコーポレイテッド	細胞媒介性免疫応答の増強方法
US5530874A (en)	1993-02-02	1996-06-25	3Com Corporation	Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en)	1993-10-07	1995-04-13	Iowa State University Research Foundation, Inc.	Characterization of mycoplasma hyopneumoniae adhesins
AU711350B2 (en)	1994-05-10	1999-10-14	Zoetis Services Llc	Improved modified live BRSV vaccine
US5788962A (en)	1995-01-17	1998-08-04	The Curators Of The University Of Missouri	DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) *	1995-03-16	1995-04-13	University Of Melbourne, The	Antigen composition
IL128014A (en)	1996-09-30	2003-11-23	Univ Arkansas	Method of producing active immunity with vaccine conjugate, a vaccine preparation useful for the production of said vaccine conjugate and a process for the manufacture of said vaccine
EP0846468B1 (de)	1996-12-05	2004-06-09	Akzo Nobel N.V.	Nicht-virulentes Mycoplasma synoviae und Impfstoffe desselben
CN1301180A (zh)	1997-11-26	2001-06-27	衣阿华州立大学研究基金会股份有限公司	重组猪肺炎支原体疫苗
AU6128900A (en) *	1999-09-29	2001-04-05	Pfizer Products Inc.	Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) *	2000-07-27	2003-07-01	Regents Of The University Of Minnesota	Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

2002
- 2002-06-07 IL IL15934902A patent/IL159349A0/xx unknown
- 2002-06-07 DK DK08167761.9T patent/DK2027873T3/en active
- 2002-06-07 CN CN201210389058.0A patent/CN102872456B/zh not_active Expired - Lifetime
- 2002-06-07 DE DE60229666T patent/DE60229666D1/de not_active Expired - Lifetime
- 2002-06-07 BR BR0210804-6A patent/BR0210804A/pt not_active Application Discontinuation
- 2002-06-07 NZ NZ530106A patent/NZ530106A/en not_active IP Right Cessation
- 2002-06-07 DK DK02735755.7T patent/DK1474067T4/en active
- 2002-06-07 DK DK14182639.6T patent/DK2842569T3/da active
- 2002-06-07 JP JP2003509957A patent/JP2005515162A/ja active Pending
- 2002-06-07 TN TNPCT/IB2002/002121A patent/TNSN03155A1/fr unknown
- 2002-06-07 EP EP14182639.6A patent/EP2842569B1/de not_active Revoked
- 2002-06-07 ES ES14182639T patent/ES2729579T3/es not_active Expired - Lifetime
- 2002-06-07 CZ CZ2003-3466A patent/CZ305781B6/cs not_active IP Right Cessation
- 2002-06-07 CN CN200810186079.6A patent/CN101524532B/zh not_active Expired - Lifetime
- 2002-06-07 PT PT81677619T patent/PT2027873E/pt unknown
- 2002-06-07 AP APAP/P/2003/002937A patent/AP2003002937A0/en unknown
- 2002-06-07 EA EA200301323A patent/EA009901B1/ru not_active IP Right Cessation
- 2002-06-07 HU HU0400434A patent/HU230246B1/hu unknown
- 2002-06-07 SK SK1579-2003A patent/SK288010B6/sk unknown
- 2002-06-07 ES ES08167761.9T patent/ES2550458T3/es not_active Expired - Lifetime
- 2002-06-07 ES ES02735755.7T patent/ES2312580T5/es not_active Expired - Lifetime
- 2002-06-07 AU AU2002309109A patent/AU2002309109B2/en not_active Expired
- 2002-06-07 MX MXPA03011599A patent/MXPA03011599A/es active IP Right Grant
- 2002-06-07 CN CN028133447A patent/CN1551781B/zh not_active Expired - Lifetime
- 2002-06-07 OA OA1200300344A patent/OA12638A/en unknown
- 2002-06-07 PT PT14182639T patent/PT2842569T/pt unknown
- 2002-06-07 YU YU102203A patent/YU102203A/sh unknown
- 2002-06-07 EP EP02735755.7A patent/EP1474067B2/de not_active Expired - Lifetime
- 2002-06-07 AT AT02735755T patent/ATE412426T2/de active
- 2002-06-07 HR HR20031079A patent/HRP20031079A2/hr not_active Application Discontinuation
- 2002-06-07 EP EP08167761.9A patent/EP2027873B8/de not_active Expired - Lifetime
- 2002-06-07 WO PCT/IB2002/002121 patent/WO2003003941A2/en not_active Ceased
- 2002-06-07 PL PL373367A patent/PL209773B1/pl unknown
- 2002-06-07 CA CA2451626A patent/CA2451626C/en not_active Expired - Lifetime
- 2002-06-07 PT PT02735755T patent/PT1474067E/pt unknown
- 2002-06-07 KR KR10-2004-7000044A patent/KR20040030785A/ko not_active Ceased
- 2002-06-19 US US10/174,701 patent/US6846477B2/en not_active Ceased
- 2002-06-26 DO DO2002000431A patent/DOP2002000431A/es unknown
- 2002-06-26 TW TW091114057A patent/TWI329514B/zh not_active IP Right Cessation
- 2002-07-01 AR ARP020102479A patent/AR034678A1/es not_active Application Discontinuation
- 2002-07-01 UY UY27366A patent/UY27366A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000593A patent/PE20030285A1/es not_active Application Discontinuation
- 2002-07-02 PA PA20028549701A patent/PA8549701A1/es unknown
- 2002-07-02 GT GT200200138A patent/GT200200138A/es unknown
- 2002-07-06 UA UA20031213200A patent/UA78707C2/uk unknown
2003
- 2003-12-12 ZA ZA2003/09698A patent/ZA200309698B/en unknown
- 2003-12-15 IS IS7076A patent/IS7076A/is unknown
- 2003-12-22 NO NO20035762A patent/NO342654B1/no not_active IP Right Cessation
- 2003-12-31 MA MA27468A patent/MA27047A1/fr unknown
2004
- 2004-01-26 BG BG108546A patent/BG66481B1/bg unknown
- 2004-08-12 US US10/917,130 patent/US20050013823A1/en not_active Abandoned
2009
- 2009-01-16 CY CY20091100059T patent/CY1108749T1/el unknown
2012
- 2012-03-02 US US13/411,232 patent/USRE44399E1/en not_active Expired - Lifetime
2015
- 2015-08-27 HK HK15108334.1A patent/HK1207584A1/en unknown

Also Published As

Publication number	Publication date
EP2027873B1 (de)	2015-09-09
PL209773B1 (pl)	2011-10-31
TWI329514B (en)	2010-09-01
MA27047A1 (fr)	2004-12-20
JP2005515162A (ja)	2005-05-26
DK1474067T3 (da)	2008-12-08
BG108546A (bg)	2005-02-28
DOP2002000431A (es)	2003-01-15
USRE44399E1 (en)	2013-07-30
AU2002309109B2 (en)	2007-12-13
IS7076A (is)	2003-12-15
PE20030285A1 (es)	2003-03-27
WO2003003941A3 (en)	2004-07-29
PT2842569T (pt)	2019-06-17
CY1108749T1 (el)	2014-04-09
NZ530106A (en)	2007-06-29
AR034678A1 (es)	2004-03-03
CA2451626A1 (en)	2003-01-16
DK1474067T4 (en)	2017-10-16
NO20035762L (no)	2004-02-02
HU230246B1 (hu)	2015-11-30
SK288010B6 (sk)	2012-10-02
EP2027873A1 (de)	2009-02-25
US6846477B2 (en)	2005-01-25
SK15792003A3 (sk)	2005-09-08
YU102203A (sh)	2006-05-25
ES2729579T3 (es)	2019-11-04
TNSN03155A1 (fr)	2005-12-23
UY27366A1 (es)	2003-04-30
ES2312580T5 (es)	2017-12-11
NO342654B1 (no)	2018-06-25
PL373367A1 (en)	2005-08-22
BR0210804A (pt)	2005-05-03
ES2550458T3 (es)	2015-11-10
EP1474067A4 (de)	2005-08-10
HRP20031079A2 (en)	2005-10-31
HK1068250A1 (en)	2005-04-29
US20050013823A1 (en)	2005-01-20
EP1474067A2 (de)	2004-11-10
ES2312580T3 (es)	2009-03-01
MXPA03011599A (es)	2005-03-07
CA2451626C (en)	2011-05-31
DK2027873T3 (en)	2015-11-09
CN1551781A (zh)	2004-12-01
PT2027873E (pt)	2015-11-03
EA200301323A1 (ru)	2005-06-30
CN102872456A (zh)	2013-01-16
EP2842569B1 (de)	2019-04-10
AP2003002937A0 (en)	2003-12-31
EP1474067B1 (de)	2008-10-29
HK1180224A1 (zh)	2013-10-18
EP2027873B8 (de)	2015-11-11
HUP0400434A2 (en)	2007-08-28
ATE412426T2 (de)	2008-11-15
OA12638A (en)	2006-06-15
CN1551781B (zh)	2013-01-02
ZA200309698B (en)	2014-04-30
EA009901B1 (ru)	2008-04-28
CN101524532A (zh)	2009-09-09
DK2842569T3 (da)	2019-05-20
HK1207584A1 (en)	2016-02-05
CN102872456B (zh)	2016-01-20
BG66481B1 (bg)	2015-02-27
CN101524532B (zh)	2014-03-19
EP1474067B2 (de)	2017-08-16
PA8549701A1 (es)	2003-01-24
CZ20033466A3 (cs)	2005-06-15
IL159349A0 (en)	2004-06-01
PT1474067E (pt)	2008-11-14
EP2842569A1 (de)	2015-03-04
CZ305781B6 (cs)	2016-03-16
KR20040030785A (ko)	2004-04-09
UA78707C2 (en)	2007-04-25
GT200200138A (es)	2003-05-15
US20030109473A1 (en)	2003-06-12
WO2003003941A2 (en)	2003-01-16
HK1134900A1 (zh)	2010-05-20

Publication	Publication Date	Title
DE60229666D1 (de)	2008-12-11	Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i
DE60127994D1 (de)	2007-05-31	VERBESSERTE i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VAKZINE
ATE359064T1 (de)	2007-05-15	Pharmazeutische tramadolsalze
EP1322328A4 (de)	2005-07-20	Impfstoffe zum breitbandschutz gegen von neisseria meningitidis verursachten krankheiten
DE60231704D1 (de)	2009-05-07	Absorbierender Artikel mit einer Hautpflegezusammensetzung
ATE535602T1 (de)	2011-12-15	Modifiziertes insulin mit reduzierter immunogenität
DE60021099D1 (de)	2005-08-04	Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung
NO20030823D0 (no)	2003-02-21	Vaksiner
DE60124082D1 (de)	2006-12-07	In thermoplasten verwendbare füllstoffkonzentrate
ATE533506T1 (de)	2011-12-15	Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei rindern
FI4823U1 (fi)	2001-02-16	Muunnetulla tavalla vapauttava lääkeformulaatio
DE60118008D1 (de)	2006-05-11	Pharmazeutische zusammensetzungen mit amlodipinmaleat
NO20034197L (no)	2003-11-19	Sirkulasjonsstyreanordning i et borehull
EP1322326A4 (de)	2005-08-17	Gegen das angeborene immunsystem gerichtete impfstoffe
DE60110385D1 (de)	2005-06-02	Implantierbares medizinisches gerät mit einer adiabatischen uhrbetriebenen logik
NO20030423D0 (no)	2003-01-27	Temperatursensitiv levende vaksine mot Mycoplasma hyopneumoniae
DE50200692D1 (de)	2004-09-02	Kantenanleimaggregat mit andruckrolle
ATA8762001A (de)	2002-05-15	Stuhl mit einer rückenlehne
BR0205576B8 (pt)	2013-02-19	artigo absorvente descartÁvel para ser usado com uma peÇa Íntima tipo tanga.
DE60229131D1 (de)	2008-11-13	Labiale hygienevorlage mit einer kerbe
DK1272071T3 (da)	2005-05-09	En stol
UA4243S (uk)	2000-12-15	Комплект меблів з м`яким куточком «карина-ф»
UA4253S (uk)	2000-12-15	Комплект меблів з м`яким куточком «беатріс»
NO20011711D0 (no)	2001-04-04	Stol
TR200000166A2 (tr)	2001-08-21	Dermatolojik preparat.

Legal Events

Date	Code	Title	Description
2009-09-17	8363	Opposition against the patent